Today: 3 April 2026
Hermes stock price holds near €2,055 as results near — what to watch before Monday
8 February 2026
1 min read

Hermes stock price holds near €2,055 as results near — what to watch before Monday

Paris, Feb 8, 2026, 21:15 CET — The market has shut its doors for the day.

Hermes International (HRMS.PA) finished at 2,055 euros, a 0.3% gain, as trading picks up again Monday following a subdued Friday close. Shares fluctuated from 2,001 to 2,063 euros in the previous session, according to LSEG data, and have swung between 1,992.5 and 2,957 euros over the last year. Reuters Japan

Hermès is set to report its 2025 annual results on February 12, with a company webcast kicking off at 9 a.m. in Paris. For Paris-listed consumer stocks, that announcement stands out as one of the next key updates after a volatile start to February. Hermès Finance

Timing is key here, as investors process sharp shifts in global equities, cash leaving packed trades for bargain plays. “The selloff in the names that carried markets higher may have paused,” said Tim Murray, capital markets strategy at T. Rowe Price. But there’s still a scramble—he notes investors are “chasing to buy cheaper companies.” Reuters

European markets found some footing Friday, with the STOXX 600 climbing 0.9%, according to Reuters, despite earnings surprises rattling individual stocks. The index closed the week roughly 1% higher. Reuters

Hermes faces a straightforward test right now: Was growth sustained through the end of the year without resorting to bigger discounts, and is the company able to maintain its margins as expenses and currency swings come into play?

Investors are eyeing specifics on regional demand—Asia, in particular—as well as the split between price-driven gains and volume growth. Hermes doesn’t usually give explicit guidance, though even small changes in tone can move the stock fast.

Then there’s the peer comparison. Investors in luxury tend to stack Hermes next to French competitors LVMH and Kering, as well as Swiss group Richemont. They’re scanning for any sign—however faint—that the sector’s slowdown might be lifting, or simply shifting elsewhere.

The real worry runs in the opposite direction. Hermes continues to wear the “safe” luxury label, but that comes with little room for error; if sales disappoint, management sounds wary about demand, or margins slip, the stock would probably take the hit before the tough questions even start.

The broader market action this week isn’t making things straightforward. Reuters’ “Morning Bid” podcast pointed to a packed global agenda: U.S. jobs and inflation releases, ongoing turbulence in AI-driven tech stocks—moves that often ripple through rates and currencies, sometimes hitting European exporters. Reuters

Hermes traders are left waiting for Thursday’s annual results and the follow-up briefing—those are the real triggers ahead. With the stock opening again on Monday, there’s not much on the table to work with until those numbers drop.

Stock Market Today

  • Corcept Therapeutics (CORT) Shares Show Volatility, Discounted Cash Flow Model Suggests Undervaluation
    April 3, 2026, 3:08 PM EDT. Corcept Therapeutics (CORT) shares have been volatile, with a 10.3% gain over the last week and a 20.4% rise over 30 days. Despite a 46.5% drop in the past year, the stock is up 11.2% year to date and has returned over 85% across 3 and 5 years. A Discounted Cash Flow (DCF) model estimates an intrinsic value of $332.45 per share, compared to the recent price near $42.49, indicating the stock may be undervalued by 87.2%. This DCF model discounts future free cash flows to present value, factoring analyst estimates through 2030. Corcept scores 2 out of 6 on Simply Wall St's valuation checks, reflecting mixed signals amid recent optimism and underlying business reassessment.
UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next
Previous Story

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

RBC stock nudges up — what to watch before earnings and the next Bank of Canada call
Next Story

RBC stock nudges up — what to watch before earnings and the next Bank of Canada call

Go toTop